Involves enhanced gluconeogenesis, impaired glucose utilization, and disrupted insulin signaling (e.g., via AMPK pathway). Leads to hyperglycemia and vicious cycle with lipid accumulation. This evidence concerns the gene INS and Hyperglycemia.